Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: MissionIRNewsBreaks

MissionIRNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces the Postponement of FY2021 Earnings Report, Conference Call

Posted on July 2, 2021 by MissionIR

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), a producer of premium bottled alkaline water, flavor-infused waters and CBD-infused products sold under the brand names Alkaline88(R), A88 Infused(TM) and A88CBD(TM), announced that the company has not filed its 10-K full-year fiscal year … Continue reading →

Posted in MissionIRNewsBreaks, The Alkaline Water Company Inc. WTER | Leave a comment

MissionIRNewsBreaks – FingerMotion Inc. (FNGR) Leverages Expansion Resolve, Telecom Partnerships to Build Platform

Posted on July 1, 2021 by MissionIR

FingerMotion (OTCQX: FNGR) recently released its financial results for the fiscal year ended February 28, 2021, posting “its highest revenue and year-over-year revenue growth thus far.” According to a recent article, the company’s revenue grew by 82% from the previous … Continue reading →

Posted in FingerMotion Inc. FNGR, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) UST(TM) Platform Delivers Breakthrough Results Processing One of the Most Powerful Antioxidants Known to Science

Posted on July 1, 2021 by MissionIR

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide biotechnology and other industries, today announced the successful application of its Ultra Shear Technology(TM) (“UST(TM)”) … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Business Update, Progress on Driving Berubicin’s Development

Posted on July 1, 2021 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today provided a business update. Among the highlights, the company reported on its continued … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Announces Strategic Appointments

Posted on July 1, 2021 by MissionIR

Kaival Brands (OTCQB: KAVL), the exclusive global distributor of products manufactured by Bidi Vapor LLC, today announced the appointment of George Chuang, CEO of Lucy Labs Inc., to its board of directors. “We are pleased and honored to welcome George … Continue reading →

Posted in Kaival Brands Innovations Group Inc. KAVL, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Ideanomics Inc.’s (NASDAQ: IDEX) Solectrac Appoints Agriculture and Construction Industry Veteran as CEO

Posted on July 1, 2021 by MissionIR

Ideanomics (NASDAQ: IDEX), a company focused on the convergence of financial services and industries experiencing technological disruption, today announced that its subsidiary, Solectrac, has named Mani Iyer as CEO. The appointment positions the company for manufacturing and distribution scale of … Continue reading →

Posted in Ideanomics IDEX,, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Sustainable Green Team Ltd. (SGTM) Eyes Continued Growth Through Implementing 2021 Strategy

Posted on June 30, 2021 by MissionIR

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, recently announced Q1-2021 financial results and is positioned to surpass its record-breaking 2020 performance. “The company posted $9,291,931 in revenue, $1,400,720 in … Continue reading →

Posted in MissionIRNewsBreaks, Sustainable Green Team Ltd. SGTM | Leave a comment

MissionIRNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Finalizes Supply Agreement with Two German Companies for COVID-19 PCR Test

Posted on June 30, 2021 by MissionIR

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, has inked a master supply agreement with two German diagnostics, testing, and medical logistics companies: Beovita GmbH & Co. KG and Tackleberries GmbH. … Continue reading →

Posted in MissionIRNewsBreaks, XPhyto Therapeutics Corp. XPHYF | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX) Notes Results from 2021 Annual Meeting

Posted on June 30, 2021 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX) (CSE: LXX), a global innovator in drug-delivery platforms, has released the results of its annual meeting, which was held June 28, 2021. According to the announcement, the meeting began at 1 p.m. PT with 2,735,413 company … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Releases FY 2021 Financial Results, Corporate Highlights

Posted on June 30, 2021 by MissionIR

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, has reported … Continue reading →

Posted in MissionIRNewsBreaks, VistaGen Therapeutics Inc. VTGN | Leave a comment